UCB SA NPV by UCB S.A. Financials - Benzinga

UCB SA NPV by UCB S.A.

UCBJFOTCPK

Trade with Public

Trade with Public

$250.88

-16.71-6.24%

At close: Aug 28, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

UCB SA NPV by UCB S.A. Financials

UCB SA NPV by UCB S.A. (UCBJF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Biogen, UCB Annouince Agreements to Commercialize MS, Hemophilia Therapies in Asia

Benzinga

Amgen Announces Romosozumab Phase 2 Data Published In NEJM Show Significant Increases In Bone Mineral Density

Benzinga